Well, you never know ..... 'Healthcare player BTG on the lookout...

Well, you never know .....

'Healthcare player BTG on the lookout for acquisitions as profits more than double'

copyright link/business/2016/05/17/healthcare-player-btg-on-the-lookout-for-acquisitions-as-profits/


'BTG, the technology healthcare company that develops products to shrink liver tumours and zap blood clots, has enjoyed a “coming of age”, its boss has said, after revealing that profits more than doubled last year.
Louise Makin, chief executive, said years of investment in BTG's pipeline, including tiny beads that can be inserted into the body to kill tumours and a device that dissolves blood clots in lungs, had paid off, as those products have entered the market and delivered growing revenue streams for the company.
FTSE 250-listed BTG was now in a position where it could continue to invest heavily in R&D and make strategic acquisitions, she said, all the while benefiting from an increasing trend that has seen the lines between healthcare technology and pharmaceuticals blur.
“The way we think about this is it represents us coming of age," she said.'

....
'Accordingly, R&D spending is set to rise to between £85m and £95m next year, from £77.2m last year, the bulk of which will be in interventional medicine, with a particular focus on oncology.
“It’s a watch this space for sure," Ms Makin said. "In every interventional oncology conference over the past 12 months, there are whole days dedicated to combining interventional medicines and immune-oncology. This is a very exciting area.”'